FEBS Press

SHERPA: Unknown

People

  1. Weigelt
    Weigelt
  2. Nandakumar
    Nandakumar
  3. Selenica
    Selenica
  4. Brogi
    Brogi
  5. Norton
    Norton
  6. Abu-Rustum
    Abu-Rustum
  7. Giri
    Giri
  8. Jungbluth
    Jungbluth
  9. Aghajanian
    Aghajanian
  10. Berger
    Berger

Groups

  1. Sloan Kettering Institute Postdocs (17)
  2. GSK Faculty (16)
  3. Department of Medicine (14)
  4. Solid Tumor Oncology Division (13)
  5. Department of Pathology and Laboratory Medicine (11)
  6. Gynecology Disease Management Team (10)
  7. GDMT, Pathology and Laboratory Medicine (9)
  8. Surgery (8)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  10. Breast Medicine Service (5)
Search Within
Formats
  1. Journal Article (34)
  2. Editorial (2)
  3. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (17)
  2. GSK Faculty (16)
  3. Department of Medicine (14)
  4. Solid Tumor Oncology Division (13)
  5. Department of Pathology and Laboratory Medicine (11)
  6. Gynecology Disease Management Team (10)

More Groups

People
  1. Britta Weigelt (9)
  2. Jorge Reis-Filho (9)
  3. Kiu Yan Charlotte Ng (7)
  4. Salvatore Piscuoglio (5)
  5. Philip Kantoff (4)
  6. Pier Selenica (4)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (6)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Molecular Oncology (37)

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancers
    Journal Article

    Favre, L.; Cohen, J.; Calderaro, J.; Pécriaux, A.; Nguyen, C. T.; Bourgoin, R.; Larnaudie, L.; Dupuy, A.; Ollier, M.; Lechapt, E.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity
    Journal Article

    Mazzu, Y. Z.; Liao, Y.; Nandakumar, S.; Sjöström, M.; Jehane, L. E.; Ghale, R.; Govindarajan, B.; Gerke, T. A.; Lee, G. S. M.; Luo, J. H.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinib
    Journal Article

    Dziadziuszko, R.; Hung, T.; Wang, K.; Choeurng, V.; Drilon, A.; Doebele, R. C.; Barlesi, F.; Wu, C.; Dennis, L.; Skoletsky, J.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: Feasibility of precision oncology biomarker detection
    Journal Article

    Cani, A. K.; Dolce, E. M.; Darga, E. P.; Hu, K.; Liu, C. J.; Pierce, J.; Bradbury, K.; Kilgour, E.; Aung, K.; Schiavon, G.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • Genomic characterization of small cell carcinomas of the uterine cervix
    Journal Article

    Schultheis, A. M.; de Bruijn, I.; Selenica, P.; Macedo, G. S.; da Silva, E. M.; Piscuoglio, S.; Jungbluth, A. A.; Park, K. J.; Klimstra, D. S.; Wardelmann, E.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix
    Journal Article

    Kim, J. K.; Marco, M. R.; Choi, S. H.; Qu, X.; Chen, C. T.; Elkabets, M.; Fairchild, L.; Chow, O.; Barriga, F. M.; Dow, L. E.; more...
    Molecular Oncology (2021)

    Fulltext@MSK | Save
  • The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
    Journal Article

    Moukarzel, L. A.; Ferrando, L.; Da Cruz Paula, A.; Brown, D. N.; Geyer, F. C.; Pareja, F.; Piscuoglio, S.; Papanastasiou, A. D.; Fusco, N.; Marchiò, C.; more...
    Molecular Oncology (2021)

    Fulltext@MSK | Save
  • An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer
    Journal Article

    Pan, C. H.; Otsuka, Y.; Sridharan, B.; Woo, M.; Leiton, C. V.; Babu, S.; Torrente Gonçalves, M.; Kawalerski, R. R.; Bai, J. D. K.; Chang, D. K.; more...
    Molecular Oncology (2020)

    Fulltext@MSK | Save
  • Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Nandakumar, S.; Chakraborty, G.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; Atiq, M.; Khan, N.; Schultz, N.; more...
    Molecular Oncology (2020)

    Fulltext@MSK | Save
  • RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors
    Journal Article

    Yuan, X.; Tang, Z.; Du, R.; Yao, Z.; Cheung, S. H.; Zhang, X.; Wei, J.; Zhao, Y.; Du, Y.; Liu, Y.; more...
    Molecular Oncology (2020)

    Fulltext@MSK | Save

    • FEBS Press – authorized name for: